$115 Million is the total value of Virtus ETF Advisers LLC's 246 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MNKKQ | Exit | MALLINCKRODT PUB LTD CO | $0 | – | -224 | -100.0% | -0.01% | – |
| L100PS | Exit | ARCONIC INC | $0 | – | -368 | -100.0% | -0.01% | – |
| SPLK | Exit | SPLUNK INC | $0 | – | -164 | -100.0% | -0.02% | – |
| GPS | Exit | GAP INC DEL | $0 | – | -440 | -100.0% | -0.02% | – |
| NOV | Exit | NATIONAL OILWELL VARCO INC | $0 | – | -424 | -100.0% | -0.02% | – |
| COG | Exit | CABOT OIL & GAS CORP | $0 | – | -532 | -100.0% | -0.02% | – |
| WYNN | Exit | WYNN RESORTS LTD | $0 | – | -88 | -100.0% | -0.02% | – |
| TMUS | Exit | T MOBILE US INC | $0 | – | -252 | -100.0% | -0.02% | – |
| SBAC | Exit | SBA COMMUNICATIONS CORP NEWcl a | $0 | – | -100 | -100.0% | -0.02% | – |
| DXC | Exit | DXC TECHNOLOGY CO | $0 | – | -184 | -100.0% | -0.02% | – |
| CMA | Exit | COMERICA INC | $0 | – | -212 | -100.0% | -0.02% | – |
| COL | Exit | ROCKWELL COLLINS INC | $0 | – | -140 | -100.0% | -0.02% | – |
| FANG | Exit | DIAMONDBACK ENERGY INC | $0 | – | -148 | -100.0% | -0.02% | – |
| NOC | Exit | NORTHROP GRUMMAN CORP | $0 | – | -68 | -100.0% | -0.03% | – |
| SHW | Exit | SHERWIN WILLIAMS CO | $0 | – | -52 | -100.0% | -0.03% | – |
| MCK | Exit | MCKESSON CORP | $0 | – | -168 | -100.0% | -0.03% | – |
| AMT | Exit | AMERICAN TOWER CORP NEW | $0 | – | -188 | -100.0% | -0.03% | – |
| NVDA | Exit | NVIDIA CORP | $0 | – | -148 | -100.0% | -0.04% | – |
| JUNO | Exit | JUNO THERAPEUTICS INC | $0 | – | -7,860 | -100.0% | -0.45% | – |
| RXDX | Exit | IGNYTA INC | $0 | – | -22,936 | -100.0% | -0.77% | – |
| UPW | Exit | PROSHARES TR | $0 | – | -23,700 | -100.0% | -1.40% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC | 31 | Q3 2023 | 1.7% |
| REGENERON PHARMACEUTICALS | 31 | Q3 2023 | 1.8% |
| INCYTE CORP | 31 | Q3 2023 | 2.1% |
| ENANTA PHARMACEUTICALS INC | 31 | Q3 2023 | 2.2% |
| EXELIXIS INC | 31 | Q3 2023 | 1.8% |
| VANDA PHARMACEUTICALS INC | 31 | Q3 2023 | 1.7% |
| IRONWOOD PHARMACEUTICALS INC | 31 | Q3 2023 | 2.0% |
| LIGAND PHARMACEUTICALS INC | 31 | Q3 2023 | 1.5% |
| GILEAD SCIENCES INC | 31 | Q3 2023 | 1.6% |
| HALOZYME THERAPEUTICS INC | 31 | Q3 2023 | 1.7% |
View Virtus ETF Advisers LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-15 |
| 13F-HR | 2023-11-07 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Virtus ETF Advisers LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.